UVB 311nm Excimer Phototherapy Lamp – Vitiligo, Psoriasis, Eczema & Pityriasis Treatment

Tired of Skin Conditions That Won't Respond to Creams? There's a Clinical Solution You Can Use at Home

Vitiligo, psoriasis, eczema, pityriasis — these aren't just skin conditions. They're daily frustrations that affect how you feel in your own body. The white patches that spread. The plaques that itch and flake. The redness that flares without warning. You've tried the topical treatments, the dietary adjustments, the specialist appointments. And yet the condition persists, because most surface-level treatments don't address the underlying biological mechanism driving it.

Narrowband UVB excimer phototherapy at 311nm does. It's the same clinical approach used in hospital dermatology units across the UK and Europe — now available in a compact home device that puts consistent, targeted treatment back in your control.

The Science Behind 311nm Excimer UVB Phototherapy

The 311nm wavelength sits at the precise point on the UV spectrum where therapeutic benefit is highest and risk is lowest. For vitiligo, it reactivates dormant melanocytes — the pigment-producing cells that have stopped functioning in depigmented patches — stimulating repigmentation over a consistent treatment course. For psoriasis, it suppresses the overactive immune response that drives rapid skin cell turnover, reducing plaques and inflammation. For eczema and pityriasis, it calms the inflammatory cascade responsible for flare-ups.

Excimer-based UVB delivery is particularly effective because it allows highly targeted treatment of affected areas without exposing surrounding healthy skin to unnecessary UV radiation. This precision makes it suitable for sensitive areas including the face, scalp, and hands.

What Problem Does This Device Solve?

The fundamental problem with clinic-based phototherapy is access. Dermatologists recommend 2–3 sessions per week for meaningful results — but private clinic sessions cost £50–£150 each, and NHS phototherapy involves waiting lists that can stretch for months. Even when you do get appointments, the logistics of attending 2–3 times per week around work and family commitments is genuinely difficult for most people.

This device removes every one of those barriers. You treat yourself at home, at the time that suits you, as often as your protocol requires. The cost of the device is typically recovered within weeks compared to private clinic fees, and the results — when treatment is consistent — are clinically comparable to in-clinic phototherapy.

Key Features

311nm Narrowband UVB Excimer Output: Delivers the clinically validated wavelength for vitiligo, psoriasis, eczema, pityriasis rosea, and rose spot treatment. Targeted, efficient, and medically aligned with dermatological best practice.

Targeted Excimer Delivery: Designed for precise application to affected skin areas, minimising exposure to healthy surrounding tissue. Suitable for face, scalp, hands, arms, torso, and legs.

CE Certified: Meets European medical device safety standards. Built to the quality benchmarks expected of clinical phototherapy equipment.

Dual Voltage (110V / 220V): Compatible with UK, European, US, and international power standards. Use at home or take it when travelling.

No Medical Supervision Required: Designed for safe, independent home use by adults who have received a dermatological diagnosis.

Durable Long-Life Lamp: Rated for thousands of hours of operation, making this a durable long-term investment in your skin health rather than an ongoing expense.

Conditions Treated

This device is clinically appropriate for: vitiligo (segmental and generalised), plaque psoriasis, guttate psoriasis, eczema (atopic dermatitis), pityriasis rosea, rose spots, and other UV-responsive dermatological conditions. Consult your dermatologist before beginning a home phototherapy programme if you have not previously undergone clinical UVB treatment.

Treatment Protocol Guidance

Begin with short exposure times — 15 to 30 seconds per treatment area — and increase gradually by 15 seconds per session as your skin tolerates. For vitiligo, most patients begin to see early repigmentation within 6 to 12 weeks of consistent 3x weekly treatment. For psoriasis, significant plaque reduction is typically observed within 4 to 8 weeks. Always wear UV-protective goggles during treatment. Do not treat the eye area or genitals directly.

Who This Is For

Ideal for adults diagnosed with a UV-responsive skin condition seeking a cost-effective, convenient alternative to ongoing clinic-based phototherapy. Particularly well-suited to those on NHS waiting lists, those maintaining results after completing a clinic programme, and those in areas with limited access to specialist dermatology services.

Specifications

Wavelength: 311nm UVB Narrowband Excimer
Power Source: Electric (AC)
Voltage: 110V / 220V (Dual Voltage)
Certification: CE Certified
Conditions Treated: Vitiligo, Psoriasis, Eczema, Pityriasis, Rose Spots
Medical Supervision Required: No (standard home use)
Number of Pieces: 1
Origin: China
Working Principle: Narrowband Ultraviolet B Excimer Phototherapy